22.692 articles found

Dopaminergic therapy and subthalamic stimulation in Parkinson's disease: a review of 5-year reports.

Romito LM, Albanese A.

J Neurol · 2010-11-01

DOI: 10.1007/s00415-010-5720-3PMID: 21080193

Evidence-based initiation of dopaminergic therapy in Parkinson's disease.

Miyasaki JM.

J Neurol · 2010-11-01

DOI: 10.1007/s00415-010-5718-xPMID: 21080195

Transcatheter cardiovascular therapeutics conference 2010 and second world Parkinson congress.

Alexander W.

P T · 2010-11-01

PMID: 21139821

Therapeutic efficacy of the neuroprotective plant adaptogen in neurodegenerative disease (Parkinson's disease as an example).

Bocharov EV, Ivanova-Smolenskaya IA, Poleshchuk VV, Kucheryanu VG, Il'enko VA, Bocharova OA.

Bull Exp Biol Med · 2010-11-01

DOI: 10.1007/s10517-010-1023-zPMID: 21165417

Quetiapine in the treatment of psychosis in Parkinson's disease.

Shotbolt P, Samuel M, David A.

Ther Adv Neurol Disord · 2010-11-01

DOI: 10.1177/1756285610389656PMID: 21179595

Deep brain stimulation shows promise for Alzheimer's, depression treatment. Doctors also now have more options in how DBS is used to treat Parkinson's disease.

Check source for author details

Duke Med Health News · 2010-11-01

PMID: 21186495

Severe tricuspid regurgitation in a patient receiving low-dose cabergoline for the treatment of acromegaly.

Izgi C, Feray H, Cevik C, Saltan Y, Mansuroglu D, Nugent K.

J Heart Valve Dis · 2010-11-01

PMID: 21214109

X-linked dystonia parkinsonism: clinical phenotype, genetics and therapeutics.

Rosales RL.

J Mov Disord · 2010-10-30

DOI: 10.14802/jmd.10009PMID: 24868378

Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.

Saavedra JM, Sánchez-Lemus E, Benicky J.

Psychoneuroendocrinology · 2010-10-29

DOI: 10.1016/j.psyneuen.2010.10.001PMID: 21035950

Site-activated chelators derived from anti-Parkinson drug rasagiline as a potential safer and more effective approach to the treatment of Alzheimer's disease.

Zheng H, Fridkin M, Youdim MB.

Neurochem Res · 2010-10-28

DOI: 10.1007/s11064-010-0293-1PMID: 20981484

1,8-NAPHTHYRIDINE-DERIVED COMPOUNDS AND THE USE THEREOF IN THE TREATMENT OF NEURODEGENERATIVE DISEASES

DE LOS RIOS SALGADO CRISTOBAL, ROMERO MARTINEZ ALEJANDRO, EGEA MAIQUEZ JAVIER, LEON MARTINEZ RAFAEL, VILLARROYA SANCHEZ MERCEDES, GARCIA LOPEZ MANUELA, GARCIA GARCIA ANTONIO, MARCO CONTELLES JOSE LUIS, SORIANO SANTAMARIA ELENA, SAMADI ABDELOUAHID, CHIOUA MOURAD.

· 2010-10-25

NOVEL ENTERIC COMBINATION THERAPY

BORODY THOMAS JULIUS.

· 2010-10-22